Hyperbaric oxygen therapy as an adjunt treatment for glioma and brain metastasis: a literature reviewCai, Tengteng Department of Radiotherapy, Shanghai Fourth People’s Hospital, School of Medicine, Tongji University, Shanghai, China Abstract The incidence and mortality rates of malignant tumors are increasing annually, with gliomas and brain metastases linked to a poor prognosis. Hyperbaric oxygen therapy is a promising treatment modality for both gliomas and brain metastases. It can alleviate tumor hypoxia and enhance radiosensitivity. When combined with other treatments for gliomas, this therapy has the potential to enhance survival rates. This review addresses the progress in research on the use of hyperbaric oxygen therapy combined with radiotherapy. For brain metastases, the combination of hyperbaric oxygen therapy and stereotactic radiosurgery is both feasible and advantagenous. This combination not only offers protection against radiation-induced brain injury but also supports the recovery of neurological and motor functions. The incidence of adverse reactions to hyperbaric oxygen therapy is relatively low, and it is safe and manageable. Future efforts should be made to investigate the mechanisms by which hyperbaric oxygen therapy combined with radiotherapy treats gliomas and brain metastases, optimize protection of the combined treatment against brain injury, minimizing adverse reactions, conducting multidisciplinary research and clinical trials, and training healthcare providers to facilitate broader clinical application. 恶性肿瘤的发病率和死亡率逐年攀升，其中胶质瘤和脑转移瘤预后尤差。高压氧治疗作为新兴治疗手段，对上述两类肿瘤均展现出潜在价值：
安全性分析显示，高压氧治疗不良反应发生率较低，整体安全可控。未来应着力于： |